Skip to main content
Clinical Trials/NCT06949046
NCT06949046CompletedNot Applicable

Effects of a Nursing-led Communication Support Program Using Mobile Health Information on Physical and Mental Status in Breast Cancer Patients Undergoing Concurrent Chemotherapy: a Randomized Controlled Trial

National Defense Medical Center, Taiwan1 site in 1 country80 target enrollmentStarted: August 1, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
80
Locations
1
Primary Endpoint
Quality of Life (EORTC QLQ-C30)

Study Overview

Brief Summary

Breast cancer is the most common malignant tumor among women. Side effects from initial chemotherapy include sleep disorders, anxiety, depression, and reduced quality of life. Mental health distress is also a major issue in cancer care. This study integrates mobile health information with a nurse-led communication support plan, aiming to improve patients' physical and mental outcomes during chemotherapy.

Detailed Description

The objective of this study is to explore the effects of a nursing-led communication support program using mobile health information on physical and mental state in breast cancer patients undergoing initial chemotherapy.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Sequential
Primary Purpose
Supportive Care
Masking
Double (Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Female
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •breast cancer initial chemotherapy

Exclusion Criteria

  • •Patients whose cancer has recurred without undergoing the first course of chemotherapy

Arms & Interventions

Nursing routine treatment

Placebo Comparator

Nursing routine treatment

Intervention: Nursing routine treatment (Other)

nursing-led communication

Experimental

nursing-led communication support

Intervention: nursing-led communication support (Other)

Outcomes

Primary Outcomes

Quality of Life (EORTC QLQ-C30)

Time Frame: Baseline, 1 month, and 2 months after enrollment

Quality of life was measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30). Scores were transformed to a 0-100 scale according to the EORTC scoring manual. Higher scores indicate better functioning and global quality of life, whereas higher symptom scores indicate greater symptom burden. Measurements were obtained at baseline, 1 month, and 2 months after enrollment.

Secondary Outcomes

  • Anxiety and Depression(Baseline, 1 month, and 2 months after enrollment)

Investigators

Sponsor
National Defense Medical Center, Taiwan
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Mei Man

Student

National Defense Medical Center, Taiwan

Study Sites (1)

Loading locations...

Similar Trials